ABSTRACT
Background Photobiomodulation therapy (PBMT) when used isolated or combined with static magnetic field (PBMT-sMF) has been proven benefits on skeletal muscle increasing performance and reducing fatigue, increasing oxygen saturation, and modulating inflammatory process. However, it is unknown whether the effects observed with this therapy on respiratory muscles will be similar to the effects previously observed on skeletal muscles.
Objective We aimed to investigate whether PBMT-sMF is able to decrease the length of stay in the intensive care unit (ICU) and to reduce the mortality rate of patients with severe COVID-19 requiring invasive mechanical ventilation, increasing the respiratory function and modulating the inflammatory process.
Methods We conducted a prospectively registered, pragmatic, triple-blinded (patients, therapists and outcome assessors), randomized, placebo-controlled trial of PBMT-sMF in patients with severe COVID-19, requiring invasive mechanical ventilation, admitted to the ICU. Patients were randomly assigned to receive either PBMT-sMF (6 sites at the lower thorax – 189 J total, and 2 sites at the neck area – 63 J total) or placebo PBMT-sMF daily during all the ICU stay. The primary outcome was length of stay in the ICU defined by either discharge or death. The secondary outcomes were survival rate, muscle function of diaphragm, change in blood tests, change in mechanical ventilation parameters and change in arterial blood gas analysis.
Results A total of 30 patients underwent randomization (with 15 assigned to PBMT-sMF and 15 to placebo) and were analyzed. The length of stay in the ICU for the placebo group was 23.06 days while for the PBMT-sMF group was 16.26. However, there was no statistically difference between groups for the length of stay in the ICU (mean difference - MD = - 6.80; 95% CI = - 18.71 to 5.11). Regarding the secondary outcomes were observed statistically differences in favor of PBMT-sMF for diaphragm thickness, fraction of inspired oxygen, partial pressure of oxygen/fraction of inspired oxygen ratio, C-reactive protein, lymphocytes count, and hemoglobin (p<0.05).
Conclusion Among patients with severe COVID-19 requiring invasive mechanical ventilation, PBMT-sMF was not statistically different than placebo to the length of stay in the ICU. However, it is important to highlight that our sample size was underpowered to detect statistical differences to the primary outcome. In contrast, PBMT-sMF increased muscle function of diaphragm, improved ventilatory parameters, decreased C-reactive protein levels and hemoglobin count, and increased lymphocytes count.
Competing Interest Statement
All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: Professor Ernesto Cesar Pinto Leal-Junior receives research support from Multi Radiance Medical (Solon - OH, USA), a laser device manufacturer. Shaiane Silva Tomazoni has a personal relationship with Ernesto Cesar Pinto Leal-Junior. Both Shaiane Silva Tomazoni and Ernesto Cesar Pinto Leal-Junior had no role in data acquisition, data curation nor data analysis. Multi Radiance Medical had no role in the planning, conducting and analysis of data of this randomized controlled trial. The remaining authors declare that they have no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationship or activities that could appear to have influenced the submitted work.
Clinical Trial
NCT04386694
Funding Statement
Multi Radiance Medical (Solon, OH, USA) provided financial support and therapeutic devices for this study. Professor Ernesto Cesar Pinto Leal Junior receives grant #310281/2017 2 from Brazilian Council of Science and Technology Development (CNPq).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was submitted and approved by the Research Ethics Committee of Associaçao Dr. Bartholomeu Tacchini/Hospital Tacchini/RS, under protocol number 3,985,226, and by the National Research Ethics Commission from Brazilian Ministry of Health (protocol number 4,021,485).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Statement of grant support: Multi Radiance Medical (Solon - OH, USA) provided financial support and therapeutic devices for this study. Professor Ernesto Cesar Pinto Leal-Junior receives grant #310281/2017–2 from Brazilian Council of Science and Technology Development (CNPq).
Roles of study sponsor and funders: Multi Radiance Medical (Solon - OH, USA) provided financial support and therapeutic devices for this study. Multi Radiance Medical had no role in the planning, conducting and analysis of data of this randomized controlled trial.
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (Supplement 1) and declare: Professor Ernesto Cesar Pinto Leal-Junior receives research support from Multi Radiance Medical (Solon - OH, USA), a laser device manufacturer. Shaiane Silva Tomazoni has a personal relationship with Ernesto Cesar Pinto Leal-Junior. Both Shaiane Silva Tomazoni and Ernesto Cesar Pinto Leal-Junior had no role in data acquisition, data curation nor data analysis. Multi Radiance Medical had no role in the planning, conducting and analysis of data of this randomized controlled trial. The remaining authors declare that they have no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationship or activities that could appear to have influenced the submitted work.
Availability of data and materials: The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
We have included revisions in order to: 1 - Correct the information regarding discharges and deaths in the flowchart. 2 - Provide a more accurate description of the treated sites, including a better image to illustrate them. 3 - Provide a more comprehensive digestion of the data to the abstract conclusion.
Data Availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
